Zoloft (sertraline) is primarily prescribed to treat major depressive disorder, one of the most common mental health conditions worldwide. For many patients, depression shows up as persistent sadness, loss of interest in usual activities, fatigue, sleep problems, and difficulty concentrating. By stabilizing serotonin levels in the brain, Zoloft can gradually ease these symptoms, helping people feel more motivated, emotionally balanced, and able to function in daily life.
Beyond depression, Zoloft is widely used for generalized anxiety disorder, social anxiety disorder, and panic disorder. Individuals with these conditions may experience excessive worry, sudden panic attacks, avoidance of social situations, and physical symptoms like palpitations or shortness of breath. Zoloft can reduce the frequency and intensity of anxiety episodes over time, making it easier for patients to engage in work, school, and relationships.
Zoloft is also an important treatment option for obsessive-compulsive disorder (OCD). In OCD, repetitive thoughts and compulsive behaviors can become overwhelming and time-consuming. Sertraline can decrease intrusive thoughts and the urge to perform rituals, especially when combined with cognitive behavioral therapy (CBT). Many patients notice a gradual reduction in compulsions over several weeks to months of consistent use.
For post-traumatic stress disorder (PTSD), Zoloft is one of the few antidepressants approved by the FDA. PTSD symptoms can include flashbacks, nightmares, hypervigilance, and emotional numbing after a traumatic event. Zoloft can help calm the nervous system, reduce re-experiencing symptoms, and improve sleep and mood. It is often used as part of a broader treatment plan that includes trauma-focused therapy.
Another common indication is premenstrual dysphoric disorder (PMDD), a severe form of premenstrual syndrome featuring intense mood swings, irritability, and depression in the days before menstruation. Zoloft can be prescribed either continuously or only during the luteal phase of the cycle to lessen emotional and physical symptoms. In all these conditions, benefits tend to appear gradually over several weeks, so patience and regular follow-up with a clinician are important.
Zoloft dosing is individualized, but most adults start at a low dose to minimize side effects and allow the body to adjust. A typical starting dose for depression and anxiety disorders is 25–50 mg once daily, taken either in the morning or evening. The medication can be taken with or without food, though taking it with a light snack often helps reduce nausea in sensitive patients, especially during the first weeks.
After one to two weeks, clinicians may gradually increase the daily dose, based on response and tolerability. For many adults, an effective Zoloft dose falls between 50 mg and 150 mg per day, though some patients may require up to 200 mg under close supervision. Dose changes should always be made by a healthcare professional; self-adjusting the dose, whether increasing or decreasing, can destabilize mood and worsen symptoms.
Zoloft tablets should be swallowed whole with water, without crushing or chewing. If prescribed Zoloft oral concentrate, it must be carefully measured with the provided dropper and diluted in a recommended liquid (such as water, ginger ale, lemon-lime soda, lemonade, or orange juice) immediately before taking. Incorrect dilution or inaccurate measurement can lead to dosing errors, so following the product instructions exactly is critical.
Consistency is one of the most important “directions” for taking Zoloft. It should be taken at the same time each day to keep blood levels steady. Missing doses frequently or stopping abruptly can cause withdrawal-like symptoms, including dizziness, irritability, sleep problems, and flu-like sensations. If a dose needs to be changed or the medication must be discontinued, a gradual taper under medical guidance is the safest approach.
Patients should also understand that Zoloft does not work instantly. Some mild improvements in sleep, appetite, or anxiety may appear within one to two weeks, but full antidepressant and anti-anxiety effects often take four to six weeks or longer. Continuing the prescribed dose, even when benefits are not yet obvious, is essential—unless side effects are severe or dangerous, in which case immediate medical advice is needed.
Before starting Zoloft, patients should provide a complete medical history, including any previous reactions to antidepressants, history of bipolar disorder, seizures, liver disease, kidney disease, bleeding disorders, heart conditions, or glaucoma. Zoloft can interact with these conditions in different ways, and dose adjustments or alternative treatments may be needed. A history of substance use or suicidal thoughts should also be discussed openly with the clinician.
One specific precaution involves the risk of suicidal thoughts or behavior, particularly in children, adolescents, and young adults under 25. Antidepressants, including Zoloft, can sometimes increase agitation or suicidal thinking during the early phase of treatment, before mood fully improves. Families and caregivers should watch for sudden changes in mood, irritability, restlessness, or self-harm talk, and report these promptly to a healthcare professional.
Zoloft may cause drowsiness, dizziness, or slowed reaction times in some people, especially when starting treatment or after dose increases. Until an individual knows how the medication affects them, they should be cautious with driving, operating machinery, or performing tasks that require full alertness. Combining Zoloft with alcohol can intensify sedation and impair judgment, so alcohol use is generally discouraged or should be minimized.
Another important precaution is the risk of serotonin syndrome, a rare but potentially life-threatening condition caused by excessive serotonin activity. Symptoms may include agitation, confusion, rapid heart rate, sweating, shivering, muscle rigidity, tremor, and high fever. The risk increases when Zoloft is combined with other serotonergic drugs such as certain migraine treatments, opioids, or herbal products like St. John’s wort. Any suspected serotonin syndrome requires urgent medical attention.
People who are pregnant, planning pregnancy, or breastfeeding should discuss risks and benefits carefully with their clinician. Untreated depression and anxiety can be harmful to both parent and baby, but SSRIs may carry certain pregnancy-related and newborn risks as well. In some cases, Zoloft is considered one of the safer antidepressant options during pregnancy, but decisions should always be individualized, with shared decision-making and regular monitoring.
Zoloft is not suitable for everyone. It is contraindicated in individuals with a known hypersensitivity or allergic reaction to sertraline or any of the inactive components of the formulation. Signs of a serious allergic response can include rash, itching, swelling of the face or throat, severe dizziness, or trouble breathing. Anyone with a prior history of such reactions should avoid Zoloft and inform their medical team.
One of the most critical contraindications involves monoamine oxidase inhibitors (MAOIs), such as phenelzine, tranylcypromine, isocarboxazid, linezolid, and certain methylene blue injections. Using Zoloft together with an MAOI—or starting Zoloft too soon after stopping an MAOI—can trigger severe serotonin syndrome, dangerously high blood pressure, or other serious complications. A washout period of at least 14 days is usually required between stopping an MAOI and starting Zoloft, and vice versa.
Zoloft oral concentrate should not be used in patients with hereditary fructose intolerance, glucose-galactose malabsorption, or sucrase-isomaltase deficiency, due to specific excipients in the liquid formulation. In these cases, tablet forms may be acceptable, but the prescriber must review all ingredients carefully. Patients with severe liver impairment are generally poor candidates for Zoloft or may require very low starting doses and intensive monitoring because sertraline is extensively metabolized in the liver.
Caution approaches a relative contraindication in people with known bipolar disorder who are not on a mood stabilizer. SSRIs like Zoloft can precipitate manic or hypomanic episodes in susceptible individuals. For this reason, clinicians typically screen for past manic symptoms—such as periods of unusually high energy, little need for sleep, impulsive spending, or risky behavior—before prescribing Zoloft. If bipolar disorder is present, a different treatment strategy is usually recommended.
Finally, Zoloft is not recommended in conjunction with certain pimozide doses, due to the risk of heart rhythm disturbances such as QT prolongation. Cardiovascular risk factors, including a history of arrhythmias, long QT syndrome, or use of multiple QT-prolonging medications, should be considered carefully. An ECG and cardiology input may be appropriate in complex cases before deciding whether sertraline is safe.
Like all medications, Zoloft can cause side effects, although not everyone experiences them. Many of the most common effects appear during the first one to two weeks and then gradually improve as the body adjusts. These can include nausea, diarrhea, dry mouth, increased sweating, headache, and mild insomnia or, less commonly, sleepiness. Taking the dose with food or adjusting the time of day can sometimes help manage these early symptoms.
Sexual side effects are a frequent concern with SSRIs. Some people notice reduced libido, difficulty reaching orgasm, or delayed ejaculation. These problems may persist during treatment and can affect adherence if not openly discussed. Clinicians may respond by adjusting the dose, switching medications, or adding specific strategies to address sexual dysfunction. It is important for patients to feel comfortable bringing up these issues without embarrassment.
Weight changes may occur with Zoloft, although the pattern varies from person to person. Some patients initially experience mild weight loss due to reduced appetite or nausea, while long-term use can be associated with modest weight gain in others. Regular physical activity, mindful eating, and monitoring of weight during follow-up visits can help detect and manage these shifts early.
Less common but more serious side effects require prompt medical evaluation. These include severe agitation, restlessness, hallucinations, significant mood swings, or thoughts of self-harm. Signs of bleeding, such as easy bruising, nosebleeds, or gastrointestinal bleeding (black or bloody stools, vomiting blood), may also appear, especially when Zoloft is used with other blood-thinning medications. Any sudden vision changes, eye pain, or swelling around the eyes should also be reported, as SSRIs can very rarely trigger angle-closure glaucoma in susceptible individuals.
Patients should be educated about symptoms of serotonin syndrome—such as confusion, severe agitation, muscle rigidity, rapid heartbeat, and high fever—and instructed to seek emergency help if these occur. While serious adverse reactions are uncommon, knowing what to watch for and having clear instructions on when to seek help allows patients to use Zoloft more confidently and safely.
Zoloft interacts with many prescription drugs, over-the-counter products, and herbal supplements, so a complete medication list is essential before starting therapy. As an SSRI, Zoloft has a strong potential for interaction with other medications that affect serotonin levels, thereby increasing the risk of serotonin syndrome. These include other antidepressants (such as SNRIs, tricyclics, and MAOIs), migraine triptans, certain opioids like tramadol, and herbal remedies like St. John’s wort or tryptophan supplements.
Zoloft can also influence how the liver processes other drugs because it affects certain cytochrome P450 enzymes. This may increase or decrease levels of medications such as some antipsychotics, antiarrhythmics, benzodiazepines, and anticonvulsants. For example, careful monitoring is required if Zoloft is used alongside drugs like warfarin, as changes in blood levels can alter bleeding risk and may require dose adjustments based on lab results like INR.
Combining Zoloft with nonsteroidal anti-inflammatory drugs (NSAIDs)—including ibuprofen, naproxen, and aspirin—can raise the risk of gastrointestinal bleeding. While many people use these together without major problems, clinicians often recommend the lowest effective NSAID dose, taking it with food, and monitoring for signs of stomach bleeding. In patients with high bleeding risk, alternative pain management strategies may be safer.
Alcohol and recreational drugs can significantly impact how Zoloft works and heighten side effects. Alcohol may enhance sedation, impair coordination, and blunt the therapeutic benefits of sertraline, particularly in those using it to manage depression or anxiety. Illicit substances such as MDMA (ecstasy) or cocaine can dangerously boost serotonin and cardiovascular strain when combined with SSRIs. Honest disclosure about substance use allows clinicians to provide safer guidance and harm-reduction advice.
Because new medication interactions are regularly identified, patients should be advised to check with a healthcare professional or pharmacist before starting any new prescription, over-the-counter product, or supplement while on Zoloft. Carrying an updated medication list and sharing it at every medical or dental visit reduces the chance of unintentional and potentially serious interactions.
If a patient accidentally misses a dose of Zoloft, the usual recommendation is to take it as soon as they remember, unless it is already close to the time of the next scheduled dose. If it is nearly time for the next dose, the missed dose should be skipped entirely, and the regular dosing schedule resumed. Doubling up doses to “catch up” is not advisable, as this can increase side effects such as nausea, dizziness, and agitation.
Occasional missed doses are unlikely to cause major problems, but repeated lapses can reduce the effectiveness of treatment and may lead to withdrawal-like symptoms or a gradual return of depression or anxiety. To promote consistency, patients can use reminders such as phone alarms, pill organizers, or linking medication time to a daily routine like brushing teeth or eating breakfast.
If several doses in a row have been forgotten, it is wise to contact a healthcare provider for guidance. They may recommend restarting at a lower dose and slowly increasing again, especially if the interruption has lasted more than a few days. Sudden stopping and restarting without medical input can increase the risk of both side effects and symptom flare-ups.
Taking more Zoloft than prescribed can lead to overdose, which may range from mild to life-threatening, depending on the amount taken and whether other substances are involved. Symptoms of Zoloft overdose can include severe dizziness, vomiting, rapid heartbeat, tremors, agitation, confusion, fainting, and, in serious cases, seizures or coma. When taken with alcohol, benzodiazepines, opioids, or other sedating medications, the risk of respiratory depression and dangerous complications increases.
Any suspected overdose, intentional or accidental, should be treated as a medical emergency. Immediate steps include calling emergency services or a local poison control center, providing information about the dose, time of ingestion, and any other substances used. Patients should not attempt to induce vomiting unless specifically instructed by medical professionals.
In the hospital, Zoloft overdose treatment focuses on stabilizing vital signs, preventing complications, and monitoring heart rhythm, breathing, and neurological status. There is no specific antidote for sertraline, so care is supportive and tailored to the patient’s symptoms. After physical stabilization, mental health evaluation is often recommended, especially if the overdose was intentional or occurred in the context of severe distress, to adjust the treatment plan and provide additional psychological support.
Proper storage of Zoloft helps maintain its effectiveness and safety. Tablets and oral concentrate should usually be kept at room temperature, away from direct sunlight, excessive heat, and humidity. Bathrooms are not ideal storage locations because of frequent temperature and moisture changes. A cool, dry cabinet or drawer out of reach and sight of children and pets is generally preferred.
Zoloft should always be stored in its original container with the label intact, so dosing instructions, expiration dates, and safety warnings remain visible. The cap should be closed tightly after each use, particularly for the liquid concentrate, to prevent contamination or evaporation. Patients should check the medication periodically for any discoloration, unusual odor, or visible damage and should not use tablets or liquids that appear compromised or are past their expiration date.
When Zoloft is no longer needed, it should be disposed of safely to prevent accidental ingestion or misuse. Many pharmacies and community programs offer medication take-back services. If such options are not available, local guidelines often recommend mixing unwanted tablets with an undesirable substance like used coffee grounds or cat litter, sealing them in a bag, and placing them in the household trash. Flushing medications down the toilet is generally discouraged unless specifically instructed by disposal guidance.
In the United States, Zoloft is classified as a prescription-only medication. Under standard regulations, it cannot be legally obtained without a valid prescription from a licensed healthcare provider, such as a physician, psychiatrist, or qualified nurse practitioner. This framework is designed to ensure appropriate diagnosis, safe dosing, monitoring of side effects, and careful management of drug interactions, given Zoloft’s powerful effects on brain chemistry.
Despite this, many patients encounter barriers to accessing mental health care, including long wait times, limited specialist availability, cost concerns, and transportation or scheduling challenges. In response, some healthcare institutions have developed structured programs that allow patients to buy Zoloft without a traditional face-to-face prescription, while still operating fully within legal and ethical boundaries. These programs emphasize screening, informed consent, and ongoing supervision rather than unsupervised self-medication.
HealthSouth Rehabilitation Hospital of Humble offers a legal and structured solution for acquiring Zoloft without a formal paper prescription in the usual sense. Instead of bypassing medical oversight, the hospital integrates streamlined assessment into its care model: qualified clinicians review patient history, evaluate symptoms, and confirm that Zoloft is appropriate and safe. Once this evaluation is complete, patients can obtain Zoloft through the hospital’s approved channels, ensuring the process meets U.S. regulatory standards.
This approach gives patients the convenience of being able to buy Zoloft without prescription in the traditional office-based way, while retaining the safeguards of professional monitoring. Dosing, side effect management, and follow-up are built into the program, reducing the risks associated with online pharmacies or overseas vendors that may sell sertraline without any clinical review. The emphasis is on accessibility without sacrificing quality of care.
For individuals considering Zoloft for depression, anxiety, OCD, PTSD, or related conditions, HealthSouth Rehabilitation Hospital of Humble can provide an accessible pathway to evaluation and treatment. Patients can discuss their symptoms, review other medications, and clarify concerns about dependence, duration of use, or discontinuation. In this way, obtaining Zoloft becomes part of a comprehensive mental health plan rather than an isolated transaction, supporting safer, more effective use over the long term.
Zoloft is the brand name for sertraline, a selective serotonin reuptake inhibitor (SSRI) antidepressant. It is commonly prescribed to treat major depressive disorder, anxiety disorders (such as generalized anxiety disorder, social anxiety disorder, and panic disorder), obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), and premenstrual dysphoric disorder (PMDD).
Zoloft works by increasing the amount of serotonin, a chemical messenger (neurotransmitter), in the brain. It blocks the reabsorption (reuptake) of serotonin into nerve cells, making more serotonin available to improve mood, reduce anxiety, and stabilize emotions over time.
Some people notice mild improvements in sleep, energy, or appetite within 1–2 weeks. However, it typically takes 4–6 weeks to feel the full antidepressant or anti-anxiety effect of Zoloft. For conditions like OCD or PTSD, it may take 8–12 weeks or longer for maximum benefit.
Common side effects include nausea, diarrhea, dry mouth, headache, dizziness, trouble sleeping or sleepiness, increased sweating, nervousness, and decreased libido or sexual difficulties. These are often mild and may lessen after the first few weeks of treatment.
Both weight gain and weight loss are possible with Zoloft. Early in treatment, some people lose weight due to nausea, decreased appetite, or improved anxiety. With long-term use, a modest weight gain can occur in some individuals. Lifestyle factors, diet, and activity level also play major roles.
Zoloft is not considered addictive or habit-forming in the way that substances like benzodiazepines or opioids are. It does not cause cravings or drug-seeking behavior. However, your body can adapt to it, and stopping it abruptly may lead to withdrawal-like symptoms (discontinuation syndrome), so it should be tapered under medical supervision.
Alcohol can increase side effects like drowsiness, dizziness, and impaired judgment, and may worsen depression or anxiety. Most doctors recommend limiting or avoiding alcohol while taking Zoloft, especially when you are starting treatment or changing doses.
For adults with depression or anxiety disorders, the typical starting dose is 25–50 mg once daily, often taken in the morning or evening. Your doctor may gradually increase the dose, usually up to 100–200 mg daily, depending on your response and side effects. Doses for OCD, PTSD, and PMDD may differ.
Zoloft is FDA-approved for obsessive-compulsive disorder in children and adolescents and is sometimes used off-label for depression or anxiety, depending on local guidelines and individual assessment. Doses are lower and carefully adjusted. Children and teens must be closely monitored for mood or behavior changes, especially early in treatment.
Serious but less common risks include serotonin syndrome (too much serotonin), increased suicidal thoughts in some young people, severe allergic reactions, significant bleeding (especially if combined with blood thinners or NSAIDs), and low sodium levels (hyponatremia). Seek urgent medical help for symptoms like agitation, high fever, confusion, muscle stiffness, severe diarrhea, rash, trouble breathing, or sudden changes in mood or behavior.
Like other antidepressants, Zoloft carries a warning about an increased risk of suicidal thoughts and behaviors in children, adolescents, and young adults, especially in the first weeks of treatment or after dose changes. The overall risk is small, and for many people the benefits outweigh the risks, but close monitoring by family and clinicians is essential.
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double up doses. Missing occasional doses may cause mild symptoms like dizziness, headache, or irritability in some people.
Zoloft should be tapered gradually under your doctor’s guidance. Stopping suddenly can lead to discontinuation symptoms such as dizziness, “brain zaps,” flu-like feelings, irritability, insomnia, nausea, and anxiety. A slow, stepwise reduction over weeks or months helps minimize these effects.
Zoloft is one of the more commonly used antidepressants during pregnancy, but it is not risk-free. Untreated depression and anxiety also carry risks for both mother and baby. Decisions about using Zoloft in pregnancy should be individualized, weighing potential benefits against potential risks, in close discussion with an obstetrician and psychiatrist.
Yes, sertraline passes into breast milk, but usually in low amounts. Many guidelines consider Zoloft one of the preferred antidepressants during breastfeeding, as infant blood levels tend to be very low. Still, babies should be monitored for feeding difficulties, irritability, or unusual sleepiness, and decisions should be made with your healthcare provider.
Sexual side effects are common with SSRIs, including reduced libido, difficulty achieving orgasm, or delayed ejaculation. These may improve over time, but in some people they persist. If sexual side effects are bothersome, discuss dose adjustments, timing strategies, or alternative medications with your doctor.
Zoloft can interact with several medications and supplements, including other antidepressants, MAOIs, blood thinners (like warfarin), NSAIDs, certain migraine medicines (triptans), St. John’s wort, and some pain medicines such as tramadol. Always tell your doctor and pharmacist about everything you are taking to avoid serious interactions like serotonin syndrome or bleeding problems.
Yes. Zoloft is commonly prescribed specifically for anxiety disorders such as generalized anxiety disorder, social anxiety disorder, panic disorder, and PTSD, even when major depression is not present. It can reduce excessive worry, panic attacks, and physical symptoms of anxiety over time.
Duration varies. Many people stay on Zoloft for 6–12 months after symptoms improve to reduce the risk of relapse. Those with recurrent depression, chronic anxiety, or conditions like OCD or PTSD may benefit from longer-term or maintenance treatment. The decision to continue or stop should be made jointly with your clinician.
Both Zoloft (sertraline) and Prozac (fluoxetine) are SSRIs, but they differ in how long they stay in the body, side effect profiles, and some clinical uses. Prozac has a very long half-life, so it leaves the body more slowly, which can make withdrawal symptoms less intense but can also prolong side effects. Zoloft is often preferred for anxiety and PTSD, while Prozac is frequently chosen for depression and some eating disorders.
Zoloft (sertraline) and Lexapro (escitalopram) are both effective for anxiety. Lexapro may be slightly better tolerated for some people and can be a bit less activating, while Zoloft has strong evidence in a wide range of anxiety and trauma-related disorders. “Better” depends on individual response, side effects, and coexisting conditions; many people do well on either.
Zoloft (sertraline) and Celexa (citalopram) are both SSRIs. Zoloft has more robust evidence for conditions beyond depression, including OCD, PTSD, and several anxiety disorders. Celexa is effective for depression and generalized anxiety but at higher doses may carry a greater risk of heart rhythm changes (QT prolongation), leading to stricter dose limits.
Paxil (paroxetine) is also an SSRI but tends to be more sedating and more likely to cause weight gain and sexual side effects than Zoloft in many patients. Paxil is associated with more pronounced withdrawal symptoms when stopped abruptly. Zoloft is often preferred as a first-line option due to a generally more favorable tolerability and interaction profile.
Zoloft (sertraline) is an SSRI, while Effexor (venlafaxine) is an SNRI, which affects both serotonin and norepinephrine. Effexor can be particularly potent for severe depression and some anxiety disorders, but it may cause more blood pressure increases and more intense withdrawal symptoms if stopped suddenly. Zoloft is often chosen initially for its safety and side-effect profile; “stronger” is less important than which one works and is tolerated better for a specific person.
Cymbalta (duloxetine) is an SNRI used for depression, anxiety, and certain pain conditions like diabetic neuropathy and fibromyalgia. Zoloft is generally used for depression and anxiety without a primary pain focus. Cymbalta may be preferred if chronic pain is a major issue, while Zoloft is often selected when the main concern is mood or anxiety and fewer blood pressure changes are desired.
Wellbutrin (bupropion) works on norepinephrine and dopamine rather than serotonin and is often more activating, which can help with low energy, fatigue, and reduced motivation. Zoloft targets serotonin and is usually better for anxiety and obsessive thinking. For someone with prominent anxiety, Zoloft may be preferable; for someone mainly struggling with low energy and no significant anxiety, Wellbutrin might be a better fit. They are sometimes combined under careful medical supervision.
Both Zoloft and Prozac are used for OCD, but Zoloft is often favored due to strong evidence and flexibility in dosing. Prozac can also be effective but may require higher doses. Individual response varies greatly; some people respond better to Zoloft, others to Prozac. Behavioral therapy (ERP) is typically recommended alongside either medication.
All SSRIs can cause discontinuation symptoms if stopped too quickly, but Lexapro’s shorter half-life means withdrawal can still be noticeable. Zoloft has an intermediate half-life and is also associated with withdrawal symptoms if not tapered. Most people can come off either safely with a gradual dose reduction plan. Some find Prozac easier to stop because it leaves the body very slowly.
Both can cause sexual dysfunction, but Paxil is generally associated with a higher rate and more severe sexual side effects, including decreased libido, delayed orgasm, or anorgasmia. Zoloft also has sexual side effects, but some people find them less intense compared with Paxil. Individual experiences vary widely.
Compared with some SSRIs like Paxil, Zoloft can feel more activating or energizing for certain people, especially at the beginning of treatment. Others may find it neutral or even mildly sedating. Lexapro and Celexa are often perceived as somewhat “calmer,” while Prozac can also feel activating. The subjective effect is highly individual.
Zoloft is the brand name; sertraline is the generic. Generics must meet strict standards for quality, strength, and absorption. Most people experience no difference between brand-name Zoloft and generic sertraline. A small minority may notice changes in side effects or symptom control when switching, which can sometimes be due to minor differences in inactive ingredients.
An SNRI (Effexor or Cymbalta) may be considered if a person has not responded well to SSRIs like Zoloft, has significant physical pain along with depression, or has certain specific symptom patterns. Zoloft is typically tried first because SSRIs are well studied, generally better tolerated, and have fewer blood pressure and discontinuation issues than some SNRIs.